Bio Protocol Secures $6.9M from Maelstrom and Animoca to Integrate Blockchain with Biotechnology

Bio Protocol has successfully raised $6.9 million in a strategic funding round led by Maelstrom Fund and Animoca Brands, with participation from several prominent investors. The initiative aims to bridge the gap between biotechnology and decentralized technologies, fostering innovation in scientific research and data management. By leveraging blockchain infrastructure, Bio Protocol intends to enhance transparency, security, and collaboration in biotech processes, potentially accelerating breakthroughs in healthcare and life sciences. The funding will support the development of tools that enable seamless integration of cryptographic systems with biotech applications, empowering researchers and institutions worldwide. This investment underscores growing confidence in the convergence of cutting-edge technological fields to address complex global challenges.